Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/20/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications

Sintilimab plus autologous NK cells as second-line treatment for advanced non-small-cell lung cancer previous treated with platinum-containing chemotherapy.

Condition: Non-Small Cell Lung Cancer (NSCLC)
Journal: Frontiers in immunology
Treatment Used: Sintilimab Plus Autologous NK Cells
Number of Patients: 20
Published: December 26, 2022

Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study: Volanesorsen in FPLD; The BROADEN Study.

Condition: Familial Partial Lipodystrophy (FPLD) and Concomitant Hypertriglyceridemia and Diabetes
Journal: Journal of clinical lipidology
Treatment Used: Volanesorsen
Number of Patients: 40
Published: November 19, 2022

Tolerance and response to ketogenic therapy in neonates and infants younger than 4 months. Case series in a hospital center in Medellin, Colombia.

Condition: Neonates with Refractory Epilepsy
Journal: Revista de neurologia
Treatment Used: Ketogenic Therapy (KT)
Number of Patients: 7
Published: November 10, 2022

Anlotinib plus chemotherapy for T790M-negative EGFR-mutant non-sqNSCLC resistant to TKIs: A multicenter phase 1b/2 trial.

Condition: T790M-Negative EGFR-Mutant Non-Squamous Cell Non-Small Cell Lung Cancer (NSCLC)
Journal: Thoracic cancer
Treatment Used: Anlotinib Plus Chemotherapy
Number of Patients: 19
Published: November 08, 2022

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.

Condition: Hypertriglyceridemia
Journal: The New England journal of medicine
Treatment Used: Pemafibrate
Number of Patients: 10497
Published: November 07, 2022

Long-term safety and efficacy of MND-2119 (self-emulsifying formulation of highly purified eicosapentaenoic acid ethyl ester) in patients with hypertriglyceridemia: Results from a multicenter, 52-week, open-label study.

Condition: Hypertriglyceridemia
Journal: Journal of clinical lipidology
Treatment Used: MND-2119
Number of Patients: 0
Published: October 06, 2022

Hypertriglyceridaemia in pregnancy: an unexpected diagnosis and its management.

Condition: Hypertriglyceridemia in Pregnancy
Journal: BMJ case reports
Treatment Used: Fat-Free Diet
Number of Patients: 1
Published: August 29, 2022

Efficacy and safety of self-emulsifying formulation of highly purified eicosapentaenoic acid ethyl ester (MND-2119) versus highly purified eicosapentaenoic acid ethyl ester in patients with hypertriglyceridemia: Results from a 12-week randomized, double-blind, active-controlled, phase 3 study.

Condition: Hypertriglyceridemia
Journal: Journal of clinical lipidology
Treatment Used: Highly Purified Eicosapentaenoic Acid Ethyl Ester (MND-2119) vs. Eicosapentaenoic Acid Ethyl Ester (EPA-E)
Number of Patients: 0
Published: July 23, 2022

Safety and efficacy of therapies for chylomicronemia.

Condition: Chylomicronemia
Journal: Expert review of clinical pharmacology
Treatment Used: Low-Fat Diet and Triglyceride-Lowering Therapies
Number of Patients: 0
Published: June 28, 2022

Phase II Study of Lorlatinib in Patients With Anaplastic Lymphoma Kinase-Positive Lung Cancer and CNS-Specific Relapse.

Condition: Anaplastic Lymphoma Kinase-Positive Lung Cancer and CNS-Specific Relapse
Journal: JCO precision oncology
Treatment Used: Lorlatinib
Number of Patients: 23
Published: May 18, 2022

Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.

Condition: Prior Myocardial Infarction (MI)
Journal: Journal of the American College of Cardiology
Treatment Used: Icosapent Ethyl
Number of Patients: 3693
Published: April 28, 2022

Successful treatment of severe hypertriglyceridemia with icosapent ethyl in a case of congenital generalized lipodystrophy type 4.

Condition: Severe Hypertriglyceridemia in Congenital Generalized Lipodystrophy Type 4
Journal: Journal of pediatric endocrinology & metabolism : JPEM
Treatment Used: Icosapent Ethyl
Number of Patients: 1
Published: April 13, 2022
Showing 1-12 of 131

Last Updated: 01/20/2023